Saltar al contenido
Merck

DOT1L regulates lung developmental epithelial cell fate and adult alveolar stem cell differentiation after acute injury.

Stem cell reports (2023-08-19)
Shanru Li, Derek Liberti, Su Zhou, Yun Ying, Jun Kong, Maria C Basil, Fabian L Cardenas-Diaz, Kazushige Shiraishi, Michael P Morley, Edward E Morrisey
RESUMEN

AT2 cells harbor alveolar stem cell activity in the lung and can self-renew and differentiate into AT1 cells during homeostasis and after injury. To identify epigenetic pathways that control the AT2-AT1 regenerative response in the lung, we performed an organoid screen using a library of pharmacological epigenetic inhibitors. This screen identified DOT1L as a regulator of AT2 cell growth and differentiation. In vivo inactivation of Dot1l leads to precocious activation of both AT1 and AT2 gene expression during lung development and accelerated AT1 cell differentiation after acute lung injury. Single-cell transcriptome analysis reveals the presence of a new AT2 cell state upon loss of Dot1l, characterized by increased expression of oxidative phosphorylation genes and changes in expression of critical transcription and epigenetic factors. Taken together, these data demonstrate that Dot1l controls the rate of alveolar epithelial cell fate acquisition during development and regeneration after acute injury.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-SFTPC Antibody, from rabbit, purified by affinity chromatography